Cloudflare posted a narrower loss in the fourth quarter after recording a double-digit jump in revenue. The shares surged 16.5% in overnight trading.

Upstart stock climbed 1.2% in overnight trading after the company delivered a beat on its top and bottom lines in Q4 2025 and issued 2026 revenue guidance exceeding the consensus estimate.

Gilead Sciences issued a 2026 financial forecast that was at the low end of analysts' expectations, including sales of its pioneering twice-yearly HIV prevention drug, and its shares fell 2.4% in overnight trading.

Robinhood's fourth-quarter revenue missed Wall Street expectations as a turbulent quarter for digital assets weighed on the company's crypto trading revenue, sending the retail brokerage's shares down 7.4% in overnight trading.

Shares of U.S.-based nuclear fuel supplier Centrus Energy slip 7.5% in overnight trading. The company forecasts full-year revenue in the range of $425 million to $475 million, below analyst estimates of $482.7 million - data compiled by LSEG

Moderna said the U.S. Food and Drug Administration will not review its approval application for its influenza vaccine, sending shares of the company down 7.9% in overnight trading.

Astera Labs shares sank 9.4% in overnight trading after the tech company reported fourth-quarter results that topped Wall Street's forecast, and announced a shake up of its management team.

Lyft forecast first-quarter adjusted core profit below expectations, hit by severe U.S. winter weather, seasonal cost pressures, and posted a surprise operating loss for 2025, sending its shares down 16.9% in overnight trading.

Mattel forecast full-year profit below Wall Street expectations after missing fourth-quarter estimates, as weak discretionary spending weighed on toy demand, sending shares of the toymaker slumping 29.3% in overnight trading.